HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonis K Moustakas Selected Research

Type 1 Diabetes Mellitus (Autoimmune Diabetes)

7/2021The KAG motif of HLA-DRB1 (β71, β74, β86) predicts seroconversion and development of type 1 diabetes.
1/2021Nine residues in HLA-DQ molecules determine with susceptibility and resistance to type 1 diabetes among young children in Sweden.
11/2020Next-Generation HLA Sequence Analysis Uncovers Seven HLA-DQ Amino Acid Residues and Six Motifs Resistant to Childhood Type 1 Diabetes.
1/2020Motifs of Three HLA-DQ Amino Acid Residues (α44, β57, β135) Capture Full Association With the Risk of Type 1 Diabetes in DQ2 and DQ8 Children.
1/2019Eleven Amino Acids of HLA-DRB1 and Fifteen Amino Acids of HLA-DRB3, 4, and 5 Include Potentially Causal Residues Responsible for the Risk of Childhood Type 1 Diabetes.
1/2019Discriminative T cell recognition of cross-reactive islet-antigens is associated with HLA-DQ8 transdimer-mediated autoimmune diabetes.
12/2018DRB4*01:01 Has a Distinct Motif and Presents a Proinsulin Epitope That Is Recognized in Subjects with Type 1 Diabetes.
3/2012Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire.
1/2012Etiopathogenesis of insulin autoimmunity.
1/2009Use of MHC II structural features in the design of vaccines for organ-specific autoimmune diseases.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonis K Moustakas Research Topics

Disease

15Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2021 - 04/2002
3Rheumatoid Arthritis
11/2017 - 10/2010
3Celiac Disease (Celiac Sprue)
11/2011 - 03/2008
2Human Influenza (Influenza)
02/2012 - 05/2008
2Autoimmune Diseases (Autoimmune Disease)
02/2012 - 01/2009

Drug/Important Bio-Agent (IBA)

10Peptides (Polypeptides)IBA
01/2019 - 04/2002
5HLA-DRB1 Chains (HLA DRB1)IBA
07/2021 - 10/2010
4HLA-DQ Antigens (HLA-DQ)IBA
01/2021 - 05/2002
4HLA-DQA1 antigen (HLA DQA1)IBA
11/2020 - 02/2006
4Insulin (Novolin)FDA Link
01/2019 - 04/2002
4EpitopesIBA
12/2018 - 05/2003
3AntigensIBA
07/2021 - 01/2009
3Amino AcidsFDA Link
11/2020 - 01/2019
3HLA-DQ8 antigenIBA
01/2019 - 11/2011
3ProinsulinIBA
12/2018 - 05/2003
2AutoantibodiesIBA
01/2019 - 01/2012
2HLA-DR Antigens (HLA-DR)IBA
12/2018 - 05/2002
2Proteins (Proteins, Gene)FDA Link
02/2012 - 01/2009
2Glutens (Glutelin)IBA
11/2011 - 03/2008
1HLA-DR4 Antigen (HLA DR4 Antigen)IBA
07/2021
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2019
1HLA-DRB3 Chains (HLA DRB3)IBA
01/2019
1Anti-Citrullinated Protein AntibodiesIBA
05/2015
1VinculinIBA
05/2015
1Biotin (Vitamin H)FDA Link
02/2012
1VaccinesIBA
01/2009
1Arginine (L-Arginine)FDA Link
05/2008
1C-PeptideIBA
05/2003
1Histocompatibility Antigens Class IIIBA
08/2002